COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Cash

<< Previous

Bullboard Posts

Next >>

Comment by Stinzoon Nov 17, 2024 2:45pm

78 Views

Post# 36317241

RE:RE:RE:RE:RE:Cash

There is a main problem with the next CEO, if he is placed there by Gagnon or Gagnon and friends, there is a high chance he will be a puppet with no real power for change.

This company needs a quick 360 degress change of attitude for any chance of success. You would need a new CEO who brings in new ambitions, new way of seing the company, new money, new shareholders...

I really hope Oats or whoever is a larger group of shareholders would have a say in the selection of the new ceo and the vision of this company. The bureaucrats do not have shareholder interest in mind.

<< Previous

Bullboard Posts

Next >>

A compelling investment opportunity for gold enthusiasts